
COSMOS Pharmaceutical Corporation (CSMYF)
CSMYF Stock Price Chart
Explore COSMOS Pharmaceutical Corporation interactive price chart. Choose custom timeframes to analyze CSMYF price movements and trends.
CSMYF Company Profile
Discover essential business fundamentals and corporate details for COSMOS Pharmaceutical Corporation (CSMYF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
4 Nov 2022
Employees
5.51K
Website
https://www.cosmospc.co.jpCEO
Hideaki Yokoyama
Description
COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. As of May 31, 2022, the company operated 1,244 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. The company was incorporated in 1983 and is headquartered in Fukuoka, Japan.
CSMYF Financial Timeline
Browse a chronological timeline of COSMOS Pharmaceutical Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Apr 2026
Upcoming earnings on 8 Jan 2026
Upcoming earnings on 14 Oct 2025
Revenue estimate is $274.38B.
Earnings released on 11 Jul 2025
EPS came in at $0.76 falling short of the estimated $0.78 by -3.08%, while revenue for the quarter reached $1.80B , beating expectations by +0.32%.
Dividend declared on 11 Jul 2025
A dividend of $0.25 per share was announced, adjusted to $0.25.
Dividend declared on 11 Jul 2025
A dividend of $0.25 per share was announced, adjusted to $0.25.
Dividend declared on 29 May 2025
A dividend of $0.26 per share was announced, adjusted to $0.26. The dividend was paid on 4 Aug 2025.
Earnings released on 14 Apr 2025
EPS came in at $0.66 surpassing the estimated $0.51 by +30.77%, while revenue for the quarter reached $1.64B , missing expectations by -11.08%.
Earnings released on 10 Jan 2025
EPS came in at $0.53 surpassing the estimated $0.43 by +23.80%, while revenue for the quarter reached $1.63B , missing expectations by -0.70%.
Dividend declared on 29 Nov 2024
A dividend of $0.21 per share was announced, adjusted to $0.21. The dividend was paid on 12 Feb 2025.
Stock split effective on 23 Oct 2024
Shares were split 2 : 1 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 11 Oct 2024
EPS came in at $0.70 surpassing the estimated $0.61 by +16.01%, while revenue for the quarter reached $1.79B , beating expectations by +0.20%.
Earnings released on 12 Jul 2024
EPS came in at $0.57 falling short of the estimated $0.61 by -7.18%, while revenue for the quarter reached $1.59B , missing expectations by -0.71%.
Dividend declared on 30 May 2024
A dividend of $0.38 per share was announced, adjusted to $0.19. The dividend was paid on 1 Aug 2024.
Earnings released on 12 Apr 2024
EPS came in at $0.97 surpassing the estimated $0.45 by +114.08%, while revenue for the quarter reached $1.59B , beating expectations by +1.18%.
Earnings released on 7 Feb 2024
EPS came in at $0.87 surpassing the estimated $0.42 by +108.79%, while revenue for the quarter reached $1.59B , beating expectations by +3.20%.
Dividend declared on 29 Nov 2023
A dividend of $0.41 per share was announced, adjusted to $0.20. The dividend was paid on 13 Feb 2024.
Earnings released on 31 Aug 2023
EPS came in at $1.13 surpassing the estimated $0.57 by +97.55%, while revenue for the quarter reached $1.65B , beating expectations by +1.97%.
Earnings released on 31 May 2023
EPS came in at $1.36 surpassing the estimated $0.62 by +120.06%, while revenue for the quarter reached $1.59B , beating expectations by +1.16%.
Dividend declared on 30 May 2023
A dividend of $0.41 per share was announced, adjusted to $0.21. The dividend was paid on 3 Aug 2023.
Earnings released on 28 Feb 2023
EPS came in at $0.92 surpassing the estimated $0.51 by +80.27%, while revenue for the quarter reached $1.48B , missing expectations by -0.85%.
Earnings released on 13 Jan 2023
EPS came in at $0.94 falling short of the estimated $1.02 by -8.24%, while revenue for the quarter reached $1.45B , beating expectations by +1.40%.
Dividend declared on 29 Nov 2022
A dividend of $0.31 per share was announced, adjusted to $0.15. The dividend was paid on 13 Feb 2023.
Earnings released on 11 Oct 2022
EPS came in at $1.11 surpassing the estimated $1.06 by +4.72%, while revenue for the quarter reached $1.47B , missing expectations by -0.19%.
Earnings released on 11 Jul 2022
EPS came in at $1.24 falling short of the estimated $1.26 by -1.59%, while revenue for the quarter reached $1.51B , missing expectations by -1.19%.
Dividend declared on 30 May 2022
A dividend of $0.31 per share was announced, adjusted to $0.16. The dividend was paid on 24 Aug 2022.
Earnings released on 11 Apr 2022
EPS came in at $1.06 falling short of the estimated $1.13 by -6.19%, while revenue for the quarter reached $1.63B , missing expectations by -0.23%.
Earnings released on 11 Jan 2022
EPS came in at $1.10 falling short of the estimated $1.17 by -5.98%, while revenue for the quarter reached $1.61B .
Dividend declared on 29 Nov 2021
A dividend of $0.35 per share was announced, adjusted to $0.18. The dividend was paid on 14 Feb 2022.
Earnings released on 11 Oct 2021
EPS came in at $1.41 falling short of the estimated $1.49 by -5.37%, while revenue for the quarter reached $1.72B .
Earnings released on 12 Jul 2021
EPS came in at $1.28 surpassing the estimated $1.06 by +20.75%, while revenue for the quarter reached $1.68B .
Dividend declared on 28 May 2021
A dividend of $0.39 per share was announced, adjusted to $0.19. The dividend was paid on 25 Aug 2021.
Earnings released on 12 Apr 2021
EPS came in at $1.96 surpassing the estimated $1.28 by +53.12%, while revenue for the quarter reached $1.67B .
Earnings released on 12 Jan 2021
EPS came in at $1.36 surpassing the estimated $1.21 by +12.40%, while revenue for the quarter reached $1.68B .
Dividend declared on 27 Nov 2020
A dividend of $0.26 per share was announced, adjusted to $0.13. The dividend was paid on 12 Feb 2021.
Earnings released on 12 Oct 2020
EPS came in at $1.79 surpassing the estimated $1.48 by +20.95%, while revenue for the quarter reached $1.78B .
CSMYF Stock Performance
Access detailed CSMYF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.